MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies

IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment

Seer and Thermo Fisher Scientific Announce Strategic Collaboration to Advance Proteomics with Integrated Platform Solution

SystImmune Secures FDA Clearance for IND Application of Novel ADC Therapy BL-M17D1 for Advanced Solid Tumors

Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma

Home
/
update
/
details

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

NextEdge Admin

14 Nov 2024

2 min 31 sec

Imaging System,Neurovascular Care,Cardiac

Philips India has introduced the advanced Azurion interventional imaging system to specialists across cardiology, neurology, vascular, and surgical fields in India. This state-of-the-art system is designed to optimize neurovascular procedures, enabling faster decision-making, treating more patients, and improving outcomes. Key features include enhanced C-arm rotation and angulation for precise imaging, 2D-to-3D imaging transitions, table-side controls that maintain the sterile field, automated beam rotation for optimal imaging angles, and a specialized head immobilizer to support stroke care.

To maximize system uptime, Philips employs AI and machine learning through the Philips Service Hub, a remote service that monitors performance and proactively addresses potential issues, ensuring uninterrupted operations. Launched at the Philips Innovation Campus in Bengaluru, Philips’ largest global R&D hub, the Azurion was showcased to 80 interventionalists from across India. According to Bharath Sesha, Managing Director of Philips Indian Subcontinent, this innovation underscores Philips' commitment to enhancing healthcare through advanced technology, research, and local manufacturing.

With advanced imaging capabilities and ergonomic gantry positioning, the Azurion improves clinician workflow, allowing faster, more accurate treatment. Arvind Vaishnav, Head of Philips Innovation Campus, highlighted the center’s role in pioneering solutions for India’s unique healthcare challenges through collaborative, end-to-end innovation.

The Azurion’s impact is evident in the field, with Dr. Santhosh Joseph from KIMSHEALTH noting its potential to revolutionize stroke care via the Direct-to-Angio-Suite feature, reducing critical response times. Dr. T.S. Kler from BLK-Max Heart & Vascular Institute emphasized the system's ability to minimize contrast use and optimize radiation dosage during heart procedures, enhancing patient and clinician safety.